Galera Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Galera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $723K, a 52.6% decline year-over-year.
  • Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.18M, a 35.5% decline year-over-year.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.56M, a 22.4% decline from 2022.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.16M, a 0.93% decline from 2021.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.23M, a 30.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.56M -$1.6M -22.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $7.16M -$67K -0.93% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $7.23M +$1.7M +30.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $5.54M +$3.15M +132% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $2.39M +$1.53M +176% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $865K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.